High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

20031,763 citationsJournal Articlebronze Open Access

Authors

J. A. Child · University of Leeds

Gareth J. Morgan · Blood Cancer UK

Faith E. Davies · Blood Cancer UK

Roger G. Owen · Blood Cancer UK

Sue Bell · Yorkshire Cancer Research

Kim Hawkins · Yorkshire Cancer Research

Julia Brown ·

Abstract

High-dose therapy with autologous stem-cell rescue is an effective first-line treatment for patients with multiple myeloma who are younger than 65 years of age.

Topics & Keywords

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Ubiquitin and proteasome pathways

UN Sustainable Development Goals

No povertyGood health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 348, Issue 19, pp. 1875-1883

DOI: 10.1056/nejmoa022340

Field-Weighted Citation Impact: 41.98